RG
GH icon

Rathbones Group’s Guardant Health GH Stock Holding History

Rathbones Group’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$26.3M Buy
175,584
+9,077
+5% +$987K 0.1% 118
2026
Q1 		$15.4M Sell
166,507
-38,606
-19% -$3.88M 0.06% 142
2025
Q4 		$21M Buy
205,113
+5,025
+3% +$450K 0.08% 128
2025
Q3 		$12.5M Sell
200,088
-5,877
-3% -$320K 0.05% 147
2025
Q2 		$10.7M Buy
205,965
+3,838
+2% +$171K 0.05% 158
2025
Q1 		$8.61M Buy
202,127
+3,166
+2% +$137K 0.04% 161
2024
Q4 		$6.08M Buy
198,961
+12,375
+7% +$348K 0.03% 186
2024
Q3 		$4.28M Buy
186,586
+78,191
+72% +$2.21M 0.02% 207
2024
Q2 		$3.13M Buy
108,395
+4,667
+4% +$109K 0.02% 225
2024
Q1 		$2.14M Buy
103,728
+8,050
+8% +$173K 0.01% 263
2023
Q4 		$2.59M Sell
95,678
-1,106
-1% -$29K 0.02% 239
2023
Q3 		$2.87M Buy
96,784
+2,347
+2% +$82.5K 0.02% 225
2023
Q2 		$3.38M Sell
94,437
-963
-1% -$27.7K 0.03% 168
2023
Q1 		$2.24M Sell
95,400
-3,119
-3% -$89.1K 0.02% 198
2022
Q4 		$2.68M Sell
98,519
-7,563
-7% -$346K 0.03% 186
2022
Q3 		$5.71M Buy
106,082
+242
+0.2% +$12.4K 0.07% 142
2022
Q2 		$4.27M Sell
105,840
-51
-0% -$2.53K 0.05% 159
2022
Q1 		$7.01M Sell
105,891
-387
-0.4% -$26.5K 0.07% 139
2021
Q4 		$10.6M Buy
106,278
+11,271
+12% +$1.17M 0.1% 123
2021
Q3 		$11.9M Buy
95,007
+17,156
+22% +$2.04M 0.13% 114
2021
Q2 		$9.67M Buy
77,851
+16,633
+27% +$2.24M 0.11% 122
2021
Q1 		$9.35M Buy
61,218
+23,513
+62% +$3.55M 0.12% 117
2020
Q4 		$4.86M Buy
37,705
+17,458
+86% +$2.01M 0.07% 141
2020
Q3 		$2.26M Buy
+20,247
New +$1.85M 0.04% 168

Other funds holding GH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Rathbones Group's GH Position: Q2 2026 in Review

Rathbones Group increased its Guardant Health (GH) stake by 5.5% in Q2 2026, buying an estimated $987K and bringing the position to 175,584 shares worth $26.3M. The position accounts for 0.1% of the portfolio, ranked #118.

Rathbones Group first reported a position in GH in Q3 2020 and has held it in 24 quarters since. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Rathbones Group held 175,584 shares of Guardant Health worth $26.3M as of Q2 2026.
  • Rathbones Group bought 9,077 Guardant Health shares in Q2 2026, an estimated $987K.
  • Guardant Health made up 0.1% of Rathbones Group's portfolio in Q2 2026, its #118 holding.
  • Rathbones Group first reported a position in Guardant Health in Q3 2020 and has held it in 24 quarters since.
  • 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Rathbones Group's 13F filing for Q2 2026, filed 23 Jul 2026.